Amneal Pharmaceuticals Inc (NYSE:AMRX) has received an average recommendation of “Hold” from the fourteen ratings firms that are currently covering the stock, Marketbeat.com reports. Three analysts have rated the stock with a sell rating, six have given a hold rating and five have given a buy rating to the company. The average twelve-month price target […]
